- Nachrichtendetail
-
31.05.2024 08:24:13 - dpa-AFX: *ABBVIE'S RISANKIZUMAB RECEIVES POSITIVE CHMP OPINION FOR TREATMENT OF ACTIVE ULCERATIVE COLITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ABBVIE INC. DL-,01 | A1J84E | Frankfurt | 157,520 | 28.06.24 08:02:46 | ±0,000 | ±0,00% | 157,580 | 159,100 | 157,520 | 157,520 |
